live attenuated varicella vaccine / Sinovac  >>  Phase 3
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
live attenuated varicella vaccine / Sinovac
NCT03555071: A Phase 3 Lot-consistency Clinical Trial of Live Attenuated Varicella Vaccine

Completed
3
1197
NA
Vaccine manufactured at commercialized scale, Vaccine manufactured at trial-scale
Sinovac (Dalian) Vaccine Technology Co., Ltd.
Varicella
05/17
09/17
NCT02981836: A Blind, Randomized and Controlled Study of Live Attenuated Varicella Vaccines

Completed
3
5997
RoW
Investigational live attenuated varicella vaccine, diluent of lyophilized vaccine
Sinovac (Dalian) Vaccine Technology Co., Ltd.
Varicella
06/17
09/17
NCT05150392: An Open-labelled Clinical Trial of Live Attenuated Varicella Vaccines to Evaluate the Immunity Persistence After Primary Immunization and Safety and Immunogenicity After the Booster Immunization

Completed
3
1193
RoW
Investigational live attenuated varicella vaccine
Sinovac (Dalian) Vaccine Technology Co., Ltd.
Varicella
08/18
08/20
NCT05015686: Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old

Enrolling by invitation
3
2400
RoW
Live attenuated varicella vaccines manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd, Live attenuated varicella vaccines manufactured by Changchun BCHT Biotechnology Co.,Ltd, Placebo
Sinovac (Dalian) Vaccine Technology Co., Ltd.
Varicella
02/22
09/26

Download Options